LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 201 filers reported holding LEGEND BIOTECH CORP in Q3 2023. The put-call ratio across all filers is 1.35 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $1,938,000 | -97.2% | 47,500 | -96.2% | 0.02% | -96.8% |
Q2 2022 | $69,237,000 | +48.7% | 1,258,850 | -1.8% | 0.52% | -16.7% |
Q1 2022 | $46,564,000 | -46.8% | 1,281,350 | -31.7% | 0.63% | -29.2% |
Q4 2021 | $87,457,000 | -7.9% | 1,876,350 | -0.1% | 0.89% | -31.0% |
Q3 2021 | $94,987,000 | +23.2% | 1,878,708 | +0.0% | 1.29% | +38.2% |
Q2 2021 | $77,107,000 | +22.6% | 1,878,374 | -13.3% | 0.93% | +20.3% |
Q1 2021 | $62,894,000 | -59.2% | 2,167,274 | -60.4% | 0.78% | -6.6% |
Q4 2020 | $154,046,000 | +82.9% | 5,470,412 | +93.6% | 0.83% | -33.7% |
Q3 2020 | $84,215,000 | -30.8% | 2,825,806 | -7.5% | 1.25% | -41.2% |
Q2 2020 | $121,757,000 | – | 3,056,342 | – | 2.13% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
FengHe Fund Management Pte. Ltd. | 997,714 | $36,257,000 | 13.28% |
JOHNSON & JOHNSON | 1,629,173 | $59,204,000 | 11.19% |
Paradigm Biocapital Advisors LP | 831,728 | $30,225,000 | 7.99% |
MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,100,542 | $39,994,000 | 5.54% |
HHLR ADVISORS, LTD. | 6,936,617 | $252,077,000 | 5.26% |
Old Well Partners, LLC | 79,700 | $2,896,000 | 1.94% |
Parkman Healthcare Partners LLC | 120,473 | $4,378,000 | 1.28% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 4,500 | $5,632,000 | 1.27% |
AtonRa Partners | 50,928 | $1,851,000 | 1.00% |
Avidity Partners Management LP | 1,095,000 | $39,792,000 | 0.83% |